Lloyd Sems - Net Worth and Insider Trading
Lloyd Sems Net Worth
The estimated net worth of Lloyd Sems is at least $4 dollars as of 2024-12-03. Lloyd Sems is the Director of Cyclacel Pharmaceuticals Inc and owns about 9 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $4. Details can be seen in Lloyd Sems's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lloyd Sems has not made any transactions after 2013-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lloyd Sems
Lloyd Sems Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lloyd Sems owns 3 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) , Determine Inc (DTRM) , and Sport-Haley Holdings Inc (SPORQ) .
Click here to see the complete history of Lloyd Sems’s form 4 insider trades.
Insider Ownership Summary of Lloyd Sems
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2013-05-21 | director |
| DTRM | Determine Inc | 2017-11-14 | director |
| SPORQ | Sport-Haley Holdings Inc | 2009-04-17 | director & other: Possible 13(d)group 10% member |
Lloyd Sems Latest Holdings Summary
Lloyd Sems currently owns a total of 1 stock. Lloyd Sems owns 9 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of May 21, 2013, with a value of $4.
Latest Holdings of Lloyd Sems
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2013-05-21 | 9 | 0.41 | 4 |
Holding Weightings of Lloyd Sems
Lloyd Sems Form 4 Trading Tracker
According to the SEC Form 4 filings, Lloyd Sems has made a total of 0 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years. The most-recent trade in Cyclacel Pharmaceuticals Inc is the acquisition of 9 shares on May 21, 2013, which cost Lloyd Sems around $99,999.
Insider Trading History of Lloyd Sems
- 1
Lloyd Sems Trading Performance
GuruFocus tracks the stock performance after each of Lloyd Sems's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lloyd Sems is -6.84%. GuruFocus also compares Lloyd Sems's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lloyd Sems within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lloyd Sems's insider trading performs compared to the benchmark.
Performance of Lloyd Sems
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.61 | | | | | |
| Relative Return to S&P 500(%) | 1.99 | | | | | |
Lloyd Sems Ownership Network
Lloyd Sems Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Lloyd Sems is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Lloyd Sems made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Lloyd Sems Mailing Address
Above is the net worth, insider trading, and ownership report for Lloyd Sems. You might contact Lloyd Sems via mailing address: C/o Sems Capital, 7 Dey Street, Suite 1101, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
